Search Results for "Warfarin In Vte"

22:12 EDT 28th May 2015 | BioPortfolio

Matching Channels

Vitamin K

Vitamin K is a group of 2-methilo-naphthoquinone derivatives. There are three notable forms of vitamin K; K1 which can be synthesized by plants, K2 which can be formed by natural bacteria in the int...

Matching News

Vitamin K Speeds Hip Fracture Surgery for Patients on Warfarin

(MedPage Today) -- Hospital stays shortened by 5 days with rapid warfarin reversal.

High INR on warfarin

The bottom line Clarify the warfarin dose that the patient is taking, and check for co-existing problems (such as liver disease or cancer), dietary changes, and intake of alcohol and other drugs that....

Warfarin in AF Patients on Dialysis: Worst of Both Worlds

Samuel Goldhaber describes the shocking findings of a study of warfarin use for AF prevention in patients on hemodialysis. on Medscape

Warfarin Time in the Therapeutic Range: Room for Improvement

Dr Samuel Goldhaber reviews a study of nationwide management of warfarin for stroke prevention in atrial fibrillation, showing poor real-world TTRs. on Medscape

Genetic Sensitivity to Warfarin Linked with Bleeding

The analysis from ENGAGE AF-TIMI 48 links variants in two genes known to alter the pharmacokinetics and pharmacodynamics of warfarin with bleeding-events rates. Heartwire from Medscape

Major Bleeds on Warfarin More Likely as BMI Rises: Analysis

The rise in risk, independent of age, smoking, and antiplatelet therapy, may stem from obese persons on warfarin needing "a higher dose and a longer time to become therapeutic," authors spec...

Why the Sudden-Onset Bruising in a Warfarin Patient?

What is the reason behind the new-onset bruising in this older man who was previously stable on warfarin? Medscape Internal Medicine

Device May Replace Warfarin for Some Patients With Atrial Fibrillation

Patients with atrial fibrillation who are at high risk for stroke now have an alternative to long-term warfarin therapy.

Matching PubMed Articles

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.

Warfarin is the most widely used oral anticoagulant worldwide, but serious bleeding complications are common. We tested whether genetic variants can identify patients who are at increased risk of blee...

Reinforcement of Warfarin Action in a Patient Administered S-1.

A case showing reinforcement of the action of warfarin and potassium in a patient administered S-1 is reported.The patient was a 71-year-old man with left upper gingival cancer.He had ventricular tach...

Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation.

Patients with non-valvular atrial fibrillation (NVAF) are at risk for stroke and systemic embolism (SSE), and this risk can be decreased with adjusted-dose warfarin. Warfarin, however, is cumbersome t...

Anticoagulation clinic versus a traditional warfarin management model.

Warfarin is the most commonly prescribed oral anticoagulant. The management of warfarin is challenging, and current guidelines fail to include a model to assist practitioners in optimizing therapeutic...

Warfarin is an Effective Modifier of Multiple UDP-Glucuronosyltransferase Enzymes: Evaluation of its Potential to Alter the Pharmacokinetics of Zidovudine.

In this study, we aimed to determine the modulatory effects of warfarin (an extensively used anticoagulant drug) and its metabolites on UDP-glucuronosyltransferase (UGT) activity and to assess the pot...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement